LADENBURG THALMANN FINANCIAL SERVICES INC. - NEOS THERAPEUTICS INC ownership

NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 46 filers reported holding NEOS THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of NEOS THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$1,0000.0%5200.0%0.00%
Q3 2019$1,0000.0%5200.0%0.00%
Q2 2019$1,0000.0%5200.0%0.00%
Q1 2019$1,0000.0%5200.0%0.00%
Q4 2018$1,000
-66.7%
5200.0%0.00%
Q3 2018$3,000
-25.0%
520
-7.5%
0.00%
Q2 2018$4,0000.0%5620.0%0.00%
Q1 2018$4,000
-20.0%
562
+8.1%
0.00%
Q4 2017$5,000
-50.0%
520
-66.2%
0.00%
Q3 2016$10,000
-28.6%
1,5370.0%0.00%
Q2 2016$14,000
-17.6%
1,5370.0%0.00%
Q1 2016$17,0001,5370.00%
Other shareholders
NEOS THERAPEUTICS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Sio Capital Management, LLC 666,729$14,008,0009.60%
DSC Advisors, L.P. 907,358$17,157,0008.33%
DAFNA Capital Management LLC 63,400$1,332,0001.32%
WALL STREET ASSOCIATES 199,343$4,188,0000.80%
Perceptive Advisors 742,132$15,592,0000.62%
EMERALD MUTUAL FUND ADVISERS TRUST 331,142$6,957,0000.46%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 458,332$9,630,0000.37%
EMERALD ADVISERS, LLC 321,313$6,751,0000.35%
Tourbillon Capital Partners, L.P. 611,686$12,852,0000.34%
DSC Advisors, L.P. 31,240$656,0000.32%
View complete list of NEOS THERAPEUTICS INC shareholders